Detection of left ventricular hypertrophy with electrocardiographic Sokolow-Lyon or Cornell voltage criteria was found to predict stroke and improve risk stratification among patients with hypertension.
Following declaration of the COVID-19 pandemic as a national emergency, there was a decrease in visits to the ED for MI, stroke, and hyperglycemic crisis.
Researchers sought to identify and characterize stroke in COVID-19 in a single healthcare system in New York.
After adjustment for confounding variables including age, race, cardiac condition, recent cannabis use was found to not be associated with acute ischemic stroke.
Decisions regarding anticoagulation therapy for patients with COVID-19 should take into account the risk for treatment-associated bleeding, including intracranial hemorrhage.
Pooled data from recent studies show that women with acute stroke are less likely to be treated with intravenous thrombolysis compared with men.
The goal of this study was to investigate the associations between SBP, DBP, and antihypertensive medication use with cognitive function at 90 days after stroke.
Uptake of guideline-directed preventive therapies is lower for patients with stroke and peripheral artery disease compared with those with coronary artery disease.
A significant delay in treatment has been observed for patients with acute ischemic stroke during the COVID-19 pandemic.
The Food and Drug Administration has approved Brilinta to reduce the risk of a first myocardial infarction or stroke in high-risk patients with coronary artery disease.
